RECENT NEWS

Facility Monitoring Systems (FMS), a trusted provider of contamination control solutions, is excited to announce that it has joined Trescal, a global leader in calibration services.

Severn Pathology in Bristol has recently gone live with its fourth LIAISON XL system. What makes this one a bit more special is that it marks production of Diasorin’s 7,000th LIAISON XL instrument.

A new diagnostic test being trialled across eight NHS hospitals could transform how thyroid lumps are assessed, potentially sparing hundreds of patients from unnecessary surgery.

The Institute of Biomedical Science (IBMS) has officially launched Congress 2025, which it says will be its most comprehensive yet, featuring diverse education, cutting-edge exhibitions, and unparalleled networking opportunities.

Twelve new mpox vaccination sites have opened across England, making it easier for eligible people to get protected.

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for individualised mRNA cancer immunotherapies (colloquially referred to as cancer vaccines).

The NHS will focus on delivering faster treatment for hundreds of thousands of patients – including for planned surgeries and emergency care – as the number of national targets is almost halved under new guidance to reform services.

A major new study aimed at identifying blood tests that could help diagnose dementia more accurately and quickly than current methods has begun recruiting patients from January 2025.

The UK Health Security Agency (UKHSA) has published an updated antimicrobial stewardship tool to support healthcare professionals across the UK prescribe the most appropriate antibiotics for patients, while protecting against antimicrobial resistance (AMR).

The UK Health Security Agency (UKHSA) has launched a world-first metagenomics initiative to aid in the rapid detection of infectious diseases that could threaten the UK.

The next POCT Innovators event, ‘Clinical Innovations EXPO – Breaking Through the Adoption Barriers’ will take place Thursday 15 May in Nottingham.

Tecan has unveiled Veya, its new liquid handling platform designed to bring efficiency, precision and compliance to laboratories of all sizes.

A new genomic test can identify which people with inflammatory bowel disease (IBD) have the highest risk of bowel cancer, according to a new study by Cancer Research UK scientists working at the Institute of Cancer Research (ICR) in London.

Trilobio, developer of whole laboratory automation solutions for advancing biology research, has introduced the first version of its comprehensive robotics, laboratory equipment and software platform at the Society for Laboratory Automation and Screening conference, SLAS2025, alongside pilot customer data, demonstrating the platform’s abilities in advancing research workflows.

Innovate UK, in partnership with the Medicines and Healthcare products Regulatory Agency (MHRA), Office for Life Sciences and the Medical Research Council (MRC), has announced seven new Centres of Excellence for Regulatory Science and Innovation (CERSIs) to help drive advancements in healthcare.

The TriVerity Test System, claimed to be the first and only molecular blood test that can both identify bacterial and viral infections and assess need for critical care, has been granted marketing authorisation by the U.S. Food and Drug Administration (FDA).

Beckman Coulter Diagnostics has announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Beckman Coulter's Access p‑Tau217/β-Amyloid 1-42 plasma ratio. This blood test is designed to aid healthcare providers identify patients with amyloid pathology associated with Alzheimer's disease.

Diasorin is pleased to welcome Tom Attride as the new Area Sales Manager for the Republic of Ireland and Northern Ireland.

Leading osmolality testing supplier Advanced Instruments has launched the newest update to its clinical line of freezing point osmometers. The OsmoPRO MAX is designed for clinical laboratories of all sizes seeking enhanced productivity through automation.

The Royal College of Pathologists (RCPath) has launched its first dedicated Workforce Strategy that advocates for pathology services that are fit for the future.